PR

Pieter Rottiers

IN Intrexon Actobiotics N.V.: 11 patents #2 of 11Top 20%
AN Actogenix N.V.: 4 patents #1 of 8Top 15%
📍 Zevergem, BE: #4 of 59 inventorsTop 7%
Overall (All Time): #306,259 of 4,157,543Top 8%
15
Patents All Time

Issued Patents All Time

Showing 1–15 of 15 patents

Patent #TitleCo-InventorsDate
12359210 Genetically modified bacteria stably expressing IL-10 and insulin Lothar Steidler 2025-07-15
12246046 Compositions and methods for the treatment of type 1 diabetes Lothar Steidler 2025-03-11
11786567 Compositions and methods for the treatment of type 1 diabetes Lothar Steidler 2023-10-17
11549118 Genetically modified bacteria stably expressing IL-10 and insulin Lothar Steidler 2023-01-10
10905727 Compositions and methods for the treatment of type 1 diabetes Lothar Steidler 2021-02-02
10858663 Genetically modified bacteria stably expressing IL-10 and insulin Lothar Steidler 2020-12-08
10668136 Treatment of immune disease by mucosal delivery of antigens using genetically modified Lactococcus Veerle Snoeck 2020-06-02
10195269 Induction of mucosal tolerance to antigens Veerle Snoeck 2019-02-05
10143729 Treatment of immune disease by mucosal delivery of antigens using genetically modified Lactococcus Veerle Snoeck 2018-12-04
9539291 Induction of mucosal tolerance to antigens Veerle Snoeck 2017-01-10
9526750 Induction of mucosal tolerance to antigens Veerle Snoeck 2016-12-27
9017662 Anti-TNF alpha producing lactic acid bacteria for the treatment of chronic enterocolitis Klaas Vandenbroucke 2015-04-28
8748126 Induction of mucosal tolerance to antigens Veerle Snoeck 2014-06-10
8524246 Treatment of immune disease by mucosal delivery of antigents using genetically modified Lactobacillus Veerle Snoeck 2013-09-03
8398995 Method of inducing immune tolerance to type I diabetes Veerle Snoeck 2013-03-19